Published in Mol Cell Biochem on April 01, 2001
Role of estrogen in angiogenesis in cardiovascular diseases. J Geriatr Cardiol (2013) 0.89
Long-term effects of estradiol replacement in the olfactory system. Exp Neurol (2012) 0.89
Positive association of the hepatic lipase gene polymorphism c.514C > T with estrogen replacement therapy response. Lipids Health Dis (2011) 0.83
Do long-term HDL-C declines associated with a first birth vary by apo E phenotype? The Coronary Artery Risk Development in Young Adults (CARDIA) study. J Womens Health (Larchmt) (2005) 0.81
Acute responses to estradiol replacement in the olfactory system of apoE-deficient and wild-type mice. Brain Res (2010) 0.77
Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study. Int J Clin Pract (2009) 1.61
Location of the RNA-processing enzymes RNase III, RNase E and RNase P in the Escherichia coli cell. Mol Microbiol (1991) 1.33
Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med (1990) 1.32
Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway. J Biol Chem (1997) 1.07
Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction. J Intern Med (2007) 1.03
Autolysis of human erythrocyte calpain produces two active enzyme forms with different cell localization. FEBS Lett (1996) 1.01
Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia. Arterioscler Thromb Vasc Biol (1995) 0.99
Increased thromboxane biosynthesis in type IIa hypercholesterolemia. Circulation (1992) 0.96
Changes in intracellular localization of calpastatin during calpain activation. Biochem J (1999) 0.95
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus. J Thromb Haemost (2010) 0.92
Known mutations of apoB account for only a small minority of hypobetalipoproteinemia. J Lipid Res (1999) 0.88
Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism. Eur J Biochem (2000) 0.88
Acyl-CoA-binding protein is a potent m-calpain activator. J Biol Chem (2000) 0.87
Primary renal angiosarcoma: a case report and review of the literature. Pathol Int (1997) 0.86
Properties of calpastatin forms in rat brain. FEBS Lett (1998) 0.85
Purification, properties & regulation of amylases produced by thermophilic Bacillus Sp. Indian J Exp Biol (1980) 0.84
Differential degradation of calpastatin by mu- and m-calpain in Ca(2+)-enriched human neuroblastoma LAN-5 cells. FEBS Lett (2000) 0.84
Partial purification and properties of thermostable intracellular amylases from a thermophilic Bacillus sp. AK-2. Acta Microbiol Pol (1984) 0.83
Effects of a phytosterol-enriched dairy product on lipids, sterols and 8-isoprostane in hypercholesterolemic patients: a multicenter Italian study. Nutr Metab Cardiovasc Dis (2008) 0.83
Modulation of rat brain calpastatin efficiency by post-translational modifications. FEBS Lett (1997) 0.82
Enhanced platelet release reaction in insulin-dependent and insulin-independent diabetic patients. Haemostasis (1982) 0.82
Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype. Arterioscler Thromb Vasc Biol (2000) 0.81
In vivo regulation of apolipoprotein A-I gene expression by estradiol and testosterone occurs by different mechanisms in inbred strains of mice. J Lipid Res (1991) 0.81
Effects of synvinolin on platelet aggregation and thromboxane B2 synthesis in type IIa hypercholesterolemic patients. Atherosclerosis (1989) 0.81
Platelet sensitivity to prostacyclin and thromboxane production in hyperlipidemic patients. Thromb Haemost (1982) 0.79
A new apolipoprotein B truncation (apo B-43.7) in familial hypobetalipoproteinemia: genetic and metabolic studies. Metabolism (1996) 0.78
Obesity and the metabolic syndrome in a student cohort from Southern Italy. Nutr Metab Cardiovasc Dis (2009) 0.78
Expression, purification and properties of recombinant E. coli ribonuclease III. Biochem Mol Biol Int (1996) 0.78
Thrombin-antithrombin III complexes in type II diabetes mellitus. J Diabetes Complications (1992) 0.77
Platelet function in patients with type 2 diabetes mellitus: the effect of glycaemic control. Diabetes Res (1989) 0.77
Down regulation of CD11b and CD18 expression in children with hypercholesterolemia: a preliminary report. Nutr Metab Cardiovasc Dis (2008) 0.76
Normal intestinal dietary fat and cholesterol absorption, intestinal apolipoprotein B (ApoB) mRNA levels, and ApoB-48 synthesis in a hypobetalipoproteinemic kindred without any ApoB truncation. Metabolism (1997) 0.76
Thromboxane biosynthesis, neutrophil and coagulative activation in type IIa hypercholesterolemia. Thromb Haemost (1995) 0.76
Dietary cholate increases plasma levels of apolipoprotein B in mice by posttranscriptional mechanisms. Int J Biochem Cell Biol (2001) 0.76
Lipoprotein(a) levels in relation to albumin concentration in childhood nephrotic syndrome. Kidney Int (1999) 0.75
Rapid screening of the LDL receptor point mutation FH-Genoa/Palermo. Mutation in brief no. 238. Online. Hum Mutat (1999) 0.75
Alcohol increases plasma levels of cholesterol diet-induced atherogenic lipoproteins and aortic atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol (1997) 0.75
[Calcitonin inhibition of insulin-stimulated gastric secretion. A possibility of selective evaluation of gastric secretory function]. Arch Sci Med (Torino) (1980) 0.75
Antifertility effect of green leaves of Artabotrys odoratissimus. J Indian Med Assoc (1968) 0.75
Molecular bases of low production rates of apolipoprotein B-100 and truncated apoB-82 in a mutant HepG2 cell line generated by targeted modification of the apolipoprotein B gene. J Lipid Res (1999) 0.75
[Formation of platelet thromboxane in a patient with type I glycogenosis]. Recenti Prog Med (1985) 0.75
Thromboxane B2 formation and platelet sensitivity to prostacyclin in insulin-dependent and insulin-independent diabetics. Thromb Res (1982) 0.75
Regulation of the apolipoprotein B in heterozygous hypobetalipoproteinemic knock-out mice expressing truncated apoB, B81. Low production and enhanced clearance of apoB cause low levels of apoB. Mol Cell Biochem (1999) 0.75
Ventricular arrhythmias in hypertensive patients with mild metabolic alterations. Minerva Cardioangiol (2003) 0.75
Platelet activation after adrenergic stimulation in hypertensive patients: effects of acebutolol. Eur Heart J (1983) 0.75
Studies on amylase synthesis by resting cells of thermophilic Bacillus sp. Indian J Exp Biol (1981) 0.75
Infantile digital fibromatosis: a study of the development and regression of cytoplasmic inclusion bodies. Mod Pathol (1995) 0.75